Alzheimer's disease (AD) is an insidious and progressive neurodegenerative disorder that
affects millions of people worldwide. Although the pathogenesis remains obscure, there are …

Neurodegenerative diseases, such as Alzheimer's disease (AD), are characterized by
massive loss of specific neurons. It is a progressive disabling, severe and fatal complex …

The accumulation of hyperphosphorylated tau protein aggregates is a key pathogenic event
in Alzheimer's disease (AD) and induces mitochondrial dysfunction and reactive oxygen …

Oxidative stress denotes the imbalance between the generation of reactive oxygen species
(ROS) and antioxidant defenses in living organisms, participating in various …

Alzheimer's disease (AD) has become a major public health problem affecting the elderly
population, and there is currently no effective treatment. Although the pathogenesis of AD is …

Redox imbalance and abnormal amyloid protein (Aβ) buildup are key factors in the etiology
of Alzheimer's disease (AD). As an antioxidant, the hydrogen molecule (H2) has the …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the
accumulation of beta-amyloid (Aβ) protein and neurofibrillary tangles in the brain, resulting …

Numerous pharmacological effects of quercetin have been illustrated, including
antiinflammation, antioxidation, and anticancer properties. In recent years, the antioxidant …

The prevalence of central nervous system (CNS) diseases is on the rise as the population
ages. The presence of various obstacles, particularly the blood-brain barrier (BBB), poses a …

Monoamine oxidase is a flavin enzyme that catalyzes the oxidation of monoamine
neurotransmitters in the brain. Various toxic by-products, aldehydes and hydrogen peroxide …